9th Annual Biomarkers Congress

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Seventh International Symposium on Melanoma and Other Cutaneous Malignancies March, 2010
2. Third Global Workshop in Melanoma November, 2009
3. Third World Meeting of Interdisciplinary Melanoma Centers November, 2009
4. Intratumoral therapy for Melanoma Third International Symposium on Cancer Metastases, San Francisco, CA May, 2009
5. Seventh World Congress on Melanoma May, 2009
6. Sixth International Symposium on Melanoma and Other Cutaneous Malignancies March, 2009
7. Second Global Workshop in Melanoma November, 2008
8. Elesclomol in Melanoma European Society of Medical Oncology (ESMO) September, 2008
9. Fifth International Symposium on Melanoma and Other Cutaneous Malignancies March, 2008
10. Third Annual Community Oncology Conference February, 2008
11. Novel Treatments in Renal Cell Carcinoma Third Annual Community Oncology Conference February, 2008
12. First Global Workshop on Melanoma November, 2007
13. Fourth International Symposium on Melanoma and Other Cutaneous Malignancies March, 2007
14. Renal Cell Carcinoma : Is Immunotherapy the Standard of Care? Oncology Congress October, 2006
15. Third International Symposium on Melanoma and Other Cutaneous Malignancies March, 2006
16. International IL-2 Conference October, 2005
17. Pittsburgh Cancer Conference October, 2005
18. Sixth World Congress on Melanoma September, 2005
19. Novel Targeted Agents in Melanoma Targeted Therapies August, 2005
20. Melanoma brain metastases Perspectives in Central Nervous System Malignancies June, 2005
21. Targeted Therapy for Melanoma 1st International Metastases Conference May, 2005
22. Meet the Professor (Melanoma) American Society of Clinical Oncology May, 2005
23. Second International Symposium on Melanoma and other Cutaneous Malignancies March, 2005
24. Melanoma: Standards of Care in the USA Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie (ADO) October, 2004
25. Melanoma Adjuvant Therapy European Society of Medical Oncology October, 2004
26. Histamine and IL-2 in Melanoma Perspectives in Melanoma September, 2004
27. Brain Metastases from Melanoma Metastasi Cerebrali: Importanza dell’Approccio Interdisciplinare September, 2004
28. 1st International Symposium on Melanoma and Other Cutaneous Malignancies April, 2004
29. Melanoma: Recent Advances in Diagnosis and Treatment Ground Rounds, University of Alabama, Birmingham April, 2004
30. Metastatic Ocular Melanoma to the Liver Ocular Oncology Congress January, 2004
31. Melanoma: Recent Advances in Diagnosis and Treatment Prespective’s In Melanoma Meeting, Miami, FL November, 2003
32. A Phase I Dose Escalation and Pharmacodynamic Study of Weekly Administered Albuleukinä in Patients with Advanced Solid Tumors AACR Meeting November, 2003
33. Melanoma: Recent Advances in Diagnosis and Treatment EORTC Meeting, Amsterdam October, 2003
34. Workshop on Cancer Biometrics: Identifying Biomarkers and Surrogates of Tumors in Patients ISBT Meeting, Bethesda MD October, 2003
35. Melanoma: Therapeutic Advances in High-Risk and Metastatic Disease UCONN – Grand Rounds December, 2002
36. Melanoma: Therapeutic Advances in High-Risk and Metastatic Disease Yale University – Grand Rounds December, 2002
37. The health-related quality-of-life impact of histamine dihydrochloride plus Interleukin-2 (IL-2) compared to IL-2 alone in patients with metastatic melanoma 2002 European Society of Medical Oncology Annual Meeting October, 2002
38. Phase II Study Of Concurrent Carboplatin/ Paclitaxel And Radiation Therapy (RT) In Patients (Pts) With Locally Advanced Inoperable Head And Neck Squamous Cell Carcinoma (HNSCC). 2002 American Society of Clinical Oncology Annual Meeting May, 2002
39. State of the Art Medical Treatment for Melanoma William J. Smith Memorial Conference Focus on Melanoma and Sarcoma April, 2002
40. Management of Radiation and Chemoradiation Induced Anemia SUNY, NY Grand Rounds March, 2002
41. Melanoma: Therapeutic Advances in High-Risk and Metastatic Disease Beaver Medical Center Grand Rounds March, 2002
42. The ECOG Interferon Trials American College of Surgeons Panel October, 2001
43. IL-2 Current Status in Malignant Melanoma 7th Annual Advances in Solid Tumors October, 2001
44. Melanoma: Therapeutic Advances in High-Risk and Metastatic Disease Brown University Ground Rounds June, 2001
45. Histamine Dihydrochloride (HD) Plus Interleukin-2(IL-2) in Patients with Metastatic Melanoma (mm): Updated Results of a Multicenter, Randomized Phase II Study and an Ongoing Phase II Study 2001 American Society of Clinical Oncology Annual Meeting May, 2001
46. Principals of Medical Oncology Head & Neck, Laryngology and Bronchoesophagology Lecture Series April, 2001
47. Histamine dihydrochloride with IL-2 increases survival in patients with ocular melanoma with liver metastases ECCO 11 March, 2001
48. Symposium on Advanced Malignant Melanoma World Health Organization Melanoma Meeting, Venice, Italy March, 2001
49. Adjuvant Therapy of Melanoma ASCO Educational Symposium November, 2000
50. Results of a randomized, multicenter, phase III study of histamine dihydrochloride plus interleukin-2 (IL-2) versus IL-2 alone in patients (pts) with metastatic melanoma European Society of Medical Oncology, Hamburg, Germany October, 2000
51. IL-2 with and without histamine for Stage IV melanoma International Society for Biologic Therapy, Berlin, Germany September, 2000



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Results of the AGENDA Trial: Does LDH Matter? Seventh International Symposium on Melanoma and Other Cutaneous Malignancies March, 2010
Welcome and Introductions Seventh International Symposium on Melanoma and Other Cutaneous Malignancies March, 2010
Working Lunch Seventh International Symposium on Melanoma and Other Cutaneous Malignancies March, 2010
Session 2: Clinical and Molecular Markers in Melanoma Seventh International Symposium on Melanoma and Other Cutaneous Malignancies March, 2010
Welcome and Introductions Seventh International Symposium on Melanoma and Other Cutaneous Malignancies March, 2010
Session 4: Approaching Advanced Melanoma Seventh International Symposium on Melanoma and Other Cutaneous Malignancies March, 2010

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.